Stockreport

Q32 Bio price target lowered to $20 from $80 at Oppenheimer [Yahoo! Finance]

Q32 Bio Inc.  (QTTB) 
PDF The firm notes Q32 Bio reported negative AD but positive AA results along with an update on clinical development plans for bempikibart. While Oppenheimer is clearly disa [Read more]